Blog Archives

NYGC Researchers Awarded Two-Year Target ALS Grant

NEW YORK, NY (August 18, 2023) — Researchers at the New York Genome Center (NYGC) are collaborating under a recent grant from Target ALS, a medical research foundation committed to the search for effective treatments for Amyotrophic Lateral Sclerosis (ALS). Hemali Phatnani, PhD, Core Faculty Member and Director of the Center for Genomics of Neurodegenerative […]